Glial Therapeutics
Organization
People
Dean Sheppard
Sources: reporter.nih.gov
Grants and prizes
R41, Targeting aVb8 integrin to restore astrocyte-microglia crosstalk to treat Alzheimer's disease, R41AG092194, $232K, 2025–2027, Jul 10, 2026
Sources: reporter.nih.gov